MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
May 15, 2007
Brian Lawler
King Fights for Its Empire King Pharmaceuticals announces another good quarter of financial results. Investors should expect more product acquisitions in the coming years. mark for My Articles similar articles
PC Magazine
September 21, 2004
Age of Empires II: The Age of Kings The king of real-time strategy games has yet to be dethroned. mark for My Articles similar articles
The Motley Fool
October 29, 2004
Bill Mann
King, Knave, or Village Idiot? Troubled King Pharmaceuticals' latest accounting woes threaten to scuttle its merger with Mylan. mark for My Articles similar articles
Salon.com
February 19, 2002
Richard Blow
The chill is gone The once-great Stephen King has been recycling his plots and characters for 20 years now. It's time he made good on his threats to retire... mark for My Articles similar articles
The Motley Fool
September 12, 2008
Brian Lawler
King's Unstoppable Urge to Merge King Pharmaceuticals announces it has increased its offer to acquire Alpharma, and it is now taking that bid directly to the shareholders. mark for My Articles similar articles
Inc.
July 2006
Darren Dahl
CEOs Are From Mars, VCs Are From Venus It's official: CEOs ans VCs see everything differently. mark for My Articles similar articles
Salon.com
November 21, 2000
Amy Reiter
"Anything Goes!" by Larry King In his new book, the CNN host reveals what it's like to talk policy with presidents and sing show tunes with Marlon Brando. mark for My Articles similar articles
Bank Systems & Technology
August 16, 2010
Matt Gunn
Customer-Centered Banking is the Future, Author Says Brett King discusses his book Bank 2.0 and the future of banking. mark for My Articles similar articles
The Motley Fool
March 21, 2011
Jim Royal
Meet the Cash Kings of Drilling Check out Transocean, the cash king of the drilling sector. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2006
Sara Calabro
King Without the Crown While most of pharma tries to convince the world that R&D is the number-one priority, one specialty company, King Pharmaceuticals, boasts that it has no lab. mark for My Articles similar articles
The Motley Fool
May 11, 2006
Rich Smith
Wall Street Snatches TOM's Crown Chinese Internet portal and wireless service provider TOM Online comes up lame with investors, despite championship results. mark for My Articles similar articles
The Motley Fool
March 3, 2009
Robert Steyer
Seeking Gain From Pain King Pharmaceuticals tries to remake itself as a pain therapy company. mark for My Articles similar articles
The Motley Fool
January 30, 2007
Rick Aristotle Munarriz
The King Gives Investors Bread and Circus If Burger King keeps growing with its franchisees as happy as The King himself, royalties will be even more generous. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 1, 2007
Brian Lawler
King Atop Its Throne After two quarters of middling revenue growth, drugmaker King Pharmaceuticals reported blowout sales and operating cash flow for its fourth quarter. mark for My Articles similar articles
The Motley Fool
November 13, 2006
Brian Lawler
King Not Loving Its Shareholders King Pharmaceuticals appears to be a company with stagnating operations, trying to grow sales via licensing or acquiring new drugs, with (at best) a shaky handling of its accounting practices. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 5, 2006
Rick Aristotle Munarriz
The King Wants to Play Burger King believes that Xbox marks the spot of opportunity. The Burger King-branded games will either be marketing genius or a classic blunder. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 30, 2006
Jim Mueller
The Listless King With two successful restaurant IPOs this year, expectations could have been higher for Burger King if it had not been so obvious that this mature company is in turnaround mode in a very competitive industry. You can see why the stock didn't take off. mark for My Articles similar articles
The Motley Fool
February 27, 2004
Zeke Ashton
King Makes a Comeback The love/hate cycle might be ready to shift again for this pharmaceutical. King Pharmaceuticals was once a beloved growth stock. Then it became an unloved drug stock suffering from intensifying competition, a poor acquisition or two, and an ongoing SEC investigation. The stock has started to come back. mark for My Articles similar articles
The Motley Fool
August 27, 2009
Rob Plaza
Send This Restaurant Stock Back Investors are excited about Burger King, but that likely won't last. mark for My Articles similar articles
The Motley Fool
February 1, 2006
Tim Hanson
The Truth About Telecom Many investors have left telecom for dead. Don't make that same mistake. Tread carefully in these waters, and remember that cash is king and foreign lands shouldn't be overlooked. mark for My Articles similar articles
AskMen.com
Brandon Dyce
Sean John I AM KING Sean Combs' latest fragrance looks to change all the rules, and I AM KING is sexy, smooth and spot-on. mark for My Articles similar articles
Registered Rep.
February 7, 2012
Jerry Gleeson
Morgan Stanley Smith Barney's King Breaks Away, Taps Dynasty for Help A Morgan Stanley Smith Barney team led by Larry King in Saratoga Springs, N.Y. left the wirehouse and started an independent registered investment advisor, King Wealth Management Group. mark for My Articles similar articles